<unk>  is an antineoplastic agent that is FDA approved for the treatment of remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.. There is a Black Box Warning for this<unk> ug as shown here.  Common adverse reactions include reversible alopecia,acute nausea and vomiting,diarrhea and abdominal pain,if extravasation occurs during administration, severe local tissue necrosis, severe cellulitis, thrombophlebitis, and painful induration can result..
Daunorubicin
Pirarubicin
Amrubicin
Epirubicin
Aclarubicin
Valrubicin
Mafosfamide
Ifosfamide